SEARCH

SEARCH BY CITATION

References

  • American Psychiatric Association. (1994) Diagnostic and Statistical Manual of Mental Disorders, 4th edn. American Psychiatric Press, Washington, DC.
  • Axelrod, J. & Tomchick, R. (1958) Enzymatic O-methylation of epinephrine and other catechols. J Biol Chem 233, 702705.
  • Barrett, J.C., Fry, B., Maller, J. & Daly, M.J. (2005) Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21, 263265.
  • Bassett, A.S. & Chow, E.W. (1999) 22q11 deletion syndrome: a genetic subtype of schizophrenia. Biol Psychiatry 46, 882891.
  • Birkett, P., Sigmundsson, T., Sharma, T., Toulopoulou, T., Griffiths, T.D., Reveley, A. & Murray, R. (2008) Executive function and genetic predisposition to schizophrenia–the Maudsley family study. Am J Med Genet B Neuropsychiatr Genet 147, 285293.
  • Cardno, A.G., Thomas, K. & McGuffin, P. (2002) Clinical variables and genetic loading for schizophrenia: analysis of published Danish adoption study data. Schizophr Bull 28, 393399.
  • Chang, H.A., Lu, R.B., Lin, W.W., Chang, C.C., Chen, C.L. & Huang, S.Y. (2007) Lack of association between dopamine D3 receptor Ser9Gly polymorphism and schizophrenia in Han Chinese population. Acta Neuropsychiatrica 19, 344350.
  • Chen, J., Lipska, B.K., Halim, N., Ma, Q.D., Matsumoto, M., Melhem, S., Kolachana, B.S., Hyde, T.M., Herman, M.M., Apud, J., Egan, M.F., Kleinman, J.E. & Weinberger, D.R. (2004) Functional analysis of genetic variation in catechol-O-methyltransferase (COMT): effects on mRNA, protein, and enzyme activity in postmortem human brain. Am J Hum Genet 75, 807821.
  • Davis, K.L., Kahn, R.S., Ko, G. & Davidson, M. (1991) Dopamine in schizophrenia: a review and reconceptualization. Am J Psychiatry 148, 14741486.
  • Durbin, R.M., Abecasis, G.R., Altshuler, D.L., Auton, A., Brooks, L.D., Gibbs, R.A., Hurles, M.E. & McVean, G.A. (2010) A map of human genome variation from population-scale sequencing. Nature 467, 10611073.
  • Endicott, J. & Spitzer, R.L. (1978) A diagnostic interview: the schedule for affective disorders and schizophrenia. Arch Gen Psychiatry 35, 837844.
  • Fan, J.B., Zhang, C.S., Gu, N.F., Li, X.W., Sun, W.W., Wang, H.Y., Feng, G.Y., St Clair, D. & He, L. (2005) Catechol-O-methyl transferase gene Val/Met functional polymorphism and risk of schizophrenia: a large-scale association study plus meta-analysis. Biol Psychiatry 57, 139144.
  • Fanous, A.H. & Kendler, K.S. (2005) Genetic heterogeneity, modifier genes, and quantitative phenotypes in psychiatric illness: searching for a framework. Mol Psychiatry 10, 613.
  • Funke, B., Malhotra, A.K., Finn, C.T., Plocik, A.M., Lake, S.L., Lencz, T., DeRosse, P., Kane, J.M. & Kucherlapati, R. (2005) COMT genetic variation confers risk for psychotic and affective disorders: a case control study. Behav Brain Funct 1, 19.
  • Gabriel, S.B., Schaffner, S.F., Nguyen, H., Moore, J.M., Roy, J., Blumenstiel, B., Higgins, J., DeFelice, M., Lochner, A., Faggart, M., Liu-Cordero, S.N., Rotimi, C., Adeyemo, A., Cooper, R., Ward, R., Lander, E.S., Daly, M.J. & Altshuler, D. (2002) The structure of haplotype blocks in the human genome. Science 296, 22252229.
  • Glatt, S.J., Faraone, S.V. & Tsuang, M.T. (2003) Association between a functional catechol O-methyltransferase gene polymorphism and schizophrenia: meta-analysis of case-control and family-based studies. Am J Psychiatry 160, 469476.
  • Hoenicka, J., Garrido, E., Martinez, I., Ponce, G., Aragues, M., Rodriguez-Jimenez, R., Espana-Serrano, L., Alvira-Botero, X., Santos, J.L., Rubio, G., Jimenez-Arriero, M.A. & Palomo, T. (2010) Gender-specific COMT Val158Met polymorphism association in Spanish schizophrenic patients. Am J Med Genet B Neuropsychiatr Genet 153B, 7985.
  • Horowitz, A., Shifman, S., Rivlin, N., Pisante, A. & Darvasi, A. (2005) A survey of the 22q11 microdeletion in a large cohort of schizophrenia patients. Schizophr Res 73, 263267.
  • Howes, O.D., Montgomery, A.J., Asselin, M.C., Murray, R.M., Valli, I., Tabraham, P., Bramon-Bosch, E., Valmaggia, L., Johns, L., Broome, M., McGuire, P.K. & Grasby, P.M. (2009) Elevated striatal dopamine function linked to prodromal signs of schizophrenia. Arch Gen Psychiatry 66, 1320.
  • Huang, S.Y., Lin, W.W., Ko, H.C., Lee, J.F., Wang, T.J., Chou, Y.H., Yin, S.J. & Lu, R.B. (2004) Possible interaction of alcohol dehydrogenase and aldehyde dehydrogenase genes with the dopamine D2 receptor gene in anxiety-depressive alcohol dependence. Alcohol Clin Exp Res 28, 374384.
  • Huang, S.Y., Lin, W.W., Wan, F.J., Chang, A.J., Ko, H.C., Wang, T.J., Wu, P.L. & Lu, R.B. (2007) Monoamine oxidase-A polymorphisms might modify the association between the dopamine D2 receptor gene and alcohol dependence. J Psychiatry Neurosci 32, 185192.
  • Huang, S.Y., Chen, H.K., Ma, K.H., Shy, M.J., Chen, J.H., Lin, W.C. & Lu, R.B. (2010) Association of promoter variants of human dopamine transporter gene with schizophrenia in Han Chinese. Schizophr Res 116, 6874.
  • Kay, S.R., Fiszbein, A. & Opler, L.A. (1987) The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull 13, 261276.
  • Lee, S.G., Joo, Y., Kim, B., Chung, S., Kim, H.L., Lee, I., Choi, B., Kim, C. & Song, K. (2005) Association of Ala72Ser polymorphism with COMT enzyme activity and the risk of schizophrenia in Koreans. Hum Genet 116, 319328.
  • Martorell, L., Costas, J., Valero, J., Gutierrez-Zotes, A., Phillips, C., Torres, M., Brunet, A., Garrido, G., Carracedo, A., Guillamat, R., Valles, V., Guitart, M., Labad, A. & Vilella, E. (2008) Analyses of variants located in estrogen metabolism genes (ESR1, ESR2, COMT and APOE) and schizophrenia. Schizophr Res 100, 308315.
  • Merikangas, K.R., Stevens, D.E., Fenton, B., Stolar, M., O’Malley, S., Woods, S.W. & Risch, N. (1998) Co-morbidity and familial aggregation of alcoholism and anxiety disorders. Psychol Med 28, 773788.
  • Munafo, M.R., Bowes, L., Clark, T.G. & Flint, J. (2005) Lack of association of the COMT (Val158/108 Met) gene and schizophrenia: a meta-analysis of case-control studies. Mol Psychiatry 10, 765770.
  • Neuhaus, A.H., Opgen-Rhein, C., Urbanek, C., Hahn, E., Ta, T.M., Seidelsohn, M., Strathmann, S., Kley, F., Wieseke, N., Sander, T. & Dettling, M. (2009) COMT Val 158 Met polymorphism is associated with cognitive flexibility in a signal discrimination task in schizophrenia. Pharmacopsychiatry 42, 141144.
  • Noble, E.P. (2003) D2 dopamine receptor gene in psychiatric and neurologic disorders and its phenotypes. Am J Med Genet B Neuropsychiatr Genet 116B, 103125.
  • Nunokawa, A., Watanabe, Y., Muratake, T., Kaneko, N., Koizumi, M. & Someya, T. (2007) No associations exist between five functional polymorphisms in the catechol-O-methyltransferase gene and schizophrenia in a Japanese population. Neurosci Res 58, 291296.
  • Okochi, T., Ikeda, M., Kishi, T., Kawashima, K., Kinoshita, Y., Kitajima, T., Yamanouchi, Y., Tomita, M., Inada, T., Ozaki, N. & Iwata, N. (2009) Meta-analysis of association between genetic variants in COMT and schizophrenia: an update. Schizophr Res 110, 140148.
  • Pompanon, F., Bonin, A., Bellemain, E. & Taberlet, P. (2005) Genotyping errors: causes, consequences and solutions. Nat Rev Genet 6, 847859.
  • Prata, D.P., Mechelli, A., Fu, C.H., Picchioni, M., Kane, F., Kalidindi, S., McDonald, C., Howes, O., Kravariti, E., Demjaha, A., Toulopoulou, T., Diforti, M., Murray, R.M., Collier, D.A. & McGuire, P.K. (2009) Opposite effects of catechol-O-methyltransferase Val158Met on cortical function in healthy subjects and patients with schizophrenia. Biol Psychiatry 65, 473480.
  • Risch, N. (1990) Linkage strategies for genetically complex traits. I. Multilocus models. Am J Hum Genet 46, 222228.
  • Schurhoff, F., Golmard, J.L., Szoke, A., Bellivier, F., Berthier, A., Meary, A., Rouillon, F. & Leboyer, M. (2004) Admixture analysis of age at onset in schizophrenia. Schizophr Res 71, 3541.
  • Shifman, S., Bronstein, M., Sternfeld, M., et al. (2002) A highly significant association between a COMT haplotype and schizophrenia. Am J Hum Genet 71, 12961302.
  • Strous, R.D., Lapidus, R., Viglin, D., Kotler, M. & Lachman, H.M. (2006) Analysis of an association between the COMT polymorphism and clinical symptomatology in schizophrenia. Neurosci Lett 393, 170173.
  • Toulopoulou, T., Picchioni, M., Rijsdijk, F., Hua-Hall, M., Ettinger, U., Sham, P. & Murray, R. (2007) Substantial genetic overlap between neurocognition and schizophrenia: genetic modeling in twin samples. Arch Gen Psychiatry 64, 13481355.
  • Tsai, S.J., Hong, C.J., Liao, D.L., Lai, I.C. & Liou, Y.J. (2004) Association study of a functional catechol-O-methyltransferase genetic polymorphism with age of onset, cognitive function, symptomatology and prognosis in chronic schizophrenia. Neuropsychobiology 49, 196200.
  • Tunbridge, E.M., Bannerman, D.M., Sharp, T. & Harrison, P.J. (2004) Catechol-o-methyltransferase inhibition improves set-shifting performance and elevates stimulated dopamine release in the rat prefrontal cortex. J Neurosci 24, 53315335.
  • Yeh, Y.W., Lu, R.B., Tao, P.L., Shih, M.C., Lin, W.W. & Huang, S.Y. (2010) Neither single-marker nor haplotype analyses support an association between the dopamine transporter gene and heroin dependence in Han Chinese. Genes Brain Behav 9, 638647.
  • Yu, R., Zhang, X.N., Huang, X.X., Ding, S.P. & Li, J.C. (2007) Association analysis of COMT polymorphisms and schizophrenia in a Chinese Han population: a case-control study. Am J Med Genet B Neuropsychiatr Genet 144B, 570573.